Annual Total Long Term Liabilities
$13.13 M
+$2.81 M+27.25%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total long term liabilities is $13.13 million, with the most recent change of +$2.81 million (+27.25%) on April 30, 2024.
- During the last 3 years, IPA annual total long term liabilities has risen by +$9.90 million (+306.70%).
- IPA annual total long term liabilities is now at all-time high.
Performance
IPA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$10.70 M
-$330.00 K-2.99%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total long term liabilities is $10.70 million, with the most recent change of -$330.00 thousand (-2.99%) on October 31, 2024.
- Over the past year, IPA quarterly long term liabilities has dropped by -$330.00 thousand (-2.99%).
- IPA quarterly long term liabilities is now -27.54% below its all-time high of $14.76 million, reached on January 31, 2024.
Performance
IPA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IPA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | -3.0% |
| 3 y3 years | +306.7% | -3.0% |
| 5 y5 years | +453.9% | -3.0% |
IPA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +306.7% | -27.5% | +743.6% |
| 5 y | 5-year | at high | +453.9% | -27.5% | +743.6% |
| alltime | all time | at high | -100.0% | -27.5% | >+9999.0% |
ImmunoPrecise Antibodies Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $10.70 M(-3.0%) |
| Jul 2024 | - | $11.03 M(-16.0%) |
| Apr 2024 | $13.13 M(+27.3%) | $13.13 M(-11.1%) |
| Jan 2024 | - | $14.76 M(+27.3%) |
| Oct 2023 | - | $11.60 M(-5.8%) |
| Jul 2023 | - | $12.31 M(+19.3%) |
| Apr 2023 | $10.32 M(+47.2%) | $10.32 M(-6.1%) |
| Jan 2023 | - | $10.99 M(+9.1%) |
| Oct 2022 | - | $10.07 M(+56.4%) |
| Jul 2022 | - | $6.44 M(-8.1%) |
| Apr 2022 | $7.01 M(+117.1%) | $7.01 M(+452.8%) |
| Jan 2022 | - | $1.27 M(-17.4%) |
| Oct 2021 | - | $1.53 M(-19.6%) |
| Jul 2021 | - | $1.91 M(-40.8%) |
| Apr 2021 | $3.23 M(+6.4%) | $3.23 M(+0.4%) |
| Jan 2021 | - | $3.21 M(-10.4%) |
| Oct 2020 | - | $3.59 M(-18.5%) |
| Jul 2020 | - | $4.40 M(+45.1%) |
| Apr 2020 | $3.03 M(+28.0%) | $3.03 M(-13.9%) |
| Jan 2020 | - | $3.52 M(-2.4%) |
| Oct 2019 | - | $3.61 M(+0.8%) |
| Jul 2019 | - | $3.58 M(+51.1%) |
| Apr 2019 | $2.37 M(-59.9%) | $2.37 M(-51.8%) |
| Jan 2019 | - | $4.91 M(-3.4%) |
| Oct 2018 | - | $5.09 M(-12.4%) |
| Jul 2018 | - | $5.80 M(-1.7%) |
| Apr 2018 | $5.91 M(>+9900.0%) | $5.91 M(+423.2%) |
| Jan 2018 | - | $1.13 M(-32.6%) |
| Oct 2017 | - | $1.67 M(>+9900.0%) |
| Jul 2017 | - | $0.00(0.0%) |
| Apr 2017 | $0.00(0.0%) | $0.00(-100.0%) |
| Jan 2017 | - | $95.90 K(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | - |
| Dec 2015 | - | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00 |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $0.00(0.0%) | - |
| Dec 2014 | - | $0.00(-100.0%) |
| Sep 2014 | - | $2700.00(>+9900.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | - |
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | - |
| Dec 2012 | - | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | - |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | - |
| Dec 2010 | - | $0.00(-100.0%) |
| Sep 2010 | - | -$300.00(<-9900.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | - |
| Dec 2009 | - | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | - |
| Dec 2008 | - | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | - |
| Dec 2003 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(-100.0%) | - |
| Dec 2001 | - | $0.00(-100.0%) |
| Dec 1997 | $300.00 | - |
| Dec 1997 | - | $300.00 |
FAQ
- What is ImmunoPrecise Antibodies annual total long term liabilities?
- What is the all time high annual total long term liabilities for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual total long term liabilities year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly long term liabilities year-on-year change?
What is ImmunoPrecise Antibodies annual total long term liabilities?
The current annual total long term liabilities of IPA is $13.13 M
What is the all time high annual total long term liabilities for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total long term liabilities is $13.13 M
What is ImmunoPrecise Antibodies annual total long term liabilities year-on-year change?
Over the past year, IPA annual total long term liabilities has changed by +$2.81 M (+27.25%)
What is ImmunoPrecise Antibodies quarterly total long term liabilities?
The current quarterly long term liabilities of IPA is $10.70 M
What is the all time high quarterly long term liabilities for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total long term liabilities is $14.76 M
What is ImmunoPrecise Antibodies quarterly long term liabilities year-on-year change?
Over the past year, IPA quarterly total long term liabilities has changed by -$330.00 K (-2.99%)